Tocqueville Asset Management’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$105K Buy
157,000
+10,000
+7% +$8.12K ﹤0.01% 545
2026
Q2
$140K Sell
147,000
-2,000
-1% -$1.85K ﹤0.01% 544
2026
Q1
$126K Buy
149,000
+77,000
+107% +$76.6K ﹤0.01% 537
2025
Q4
$62.9K Buy
+72,000
New +$77.8K ﹤0.01% 577

Other funds holding ONCY

Tocqueville Asset Management's ONCY Position: Q3 2026 in Review

Tocqueville Asset Management increased its Oncolytics Biotech (ONCY) stake by 6.8% in Q3 2026, buying an estimated $8.12K and bringing the position to 157,000 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Tocqueville Asset Management first reported a position in ONCY in Q4 2025 and has held it in 4 quarters since. The position peaked at $140K in Q2 2026. 77 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • Tocqueville Asset Management held 157,000 shares of Oncolytics Biotech worth $105K as of Q3 2026.
  • Tocqueville Asset Management bought 10,000 Oncolytics Biotech shares in Q3 2026, an estimated $8.12K.
  • Oncolytics Biotech made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q3 2026, its #545 holding.
  • Tocqueville Asset Management first reported a position in Oncolytics Biotech in Q4 2025 and has held it in 4 quarters since.
  • Tocqueville Asset Management's Oncolytics Biotech position peaked at $140K in Q2 2026.
  • 77 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Tocqueville Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.